Association between circulating specific leukocyte types and blood pressure: The Atherosclerosis Risk in Communities (ARIC) study

Journal of the American Society of Hypertension

Volumn 4, Issue 6, 2010, Pages 272-283

  Tian, Niu ^a   Penman, Alan D ^a   Mawson, Anthony R ^a   Manning Jr , R Davis ^a   Flessner, Michael F ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Hypertension; Inflammation; Lymphocyte; Neutrophil

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; EUROPEAN AMERICAN; FEMALE; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIDDLE AGED; MONOCYTE; NEOPLASM; NEUTROPHIL; PRIORITY JOURNAL; PULSE PRESSURE; RACE DIFFERENCE; REGULATORY MECHANISM; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIASTOLE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SYSTOLE; UNITED STATES;

EID: 78649904243     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2010.09.005     Document Type: Article

References (62)

1. V.L. Burt, P. Whelton, E.J. Roccella, C. Brown, J.A. Cutler, and M. Higgins Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991 Hypertension 25 1995 305 313
2. A. Palmer, C. Bulpitt, G. Beevers, E. Coles, A. Fletcher, and J. Ledingham Risk factors for ischaemic heart disease and stroke mortality in young and old hypertensive patients J Hum Hypertens 9 1995 695 697
3. S. Lewington, R. Clarke, N. Qizilbash, R. Peto, and R. Collins Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet 360 2002 1903 1913
4. Y. Ostchega, S.S. Yoon, J. Hughes, and T. Louis Hypertension awareness, treatment, and control - continued disparities in adults: United States, 2005-2006 NCHS Data Brief 2008 1 8
5. R.J. Johnson, D.I. Feig, T. Nakagawa, L.G. Sanchez-Lozada, and B. Rodriguez-Iturbe Pathogenesis of essential hypertension: historical paradigms and modern insights J Hypertens 26 2008 381 391
6. D.G. Harrison, T.J. Guzik, J. Goronzy, and C. Weyand Is hypertension an immunologic disease? Curr Cardiol Rep 10 2008 464 469
7. B. Rodriguez-Iturbe, and R.J. Johnson Role of inflammatory cells in the kidney in the induction and maintenance of hypertension Nephrol Dial Transplant 21 2006 260 263
8. P. Pauletto, and M. Rattazzi Inflammation and hypertension: the search for a link Nephrol Dial Transplant 21 2006 850 853
9. C. Chrysohoou, C. Pitsavos, D.B. Panagiotakos, J. Skoumas, and C. Stefanadis Association between prehypertension status and inflammatory markers related to atherosclerotic disease: the ATTICA Study Am J Hypertens 17 2004 568 573 (Pubitemid 38844982)
10. D.J. Kim, J.H. Noh, B.W. Lee, Y.H. Choi, J.H. Chung, and Y.K. Min The associations of total and differential white blood cell counts with obesity, hypertension, dyslipidemia and glucose intolerance in a Korean population J Korean Med Sci 23 2008 193 198
11. A. Shankar, B.E. Klein, and R. Klein Relationship between white blood cell count and incident hypertension Am J Hypertens 17 2004 233 239
12. R.F. Gillum Pathophysiology of hypertension in blacks and whites. A review of the basis of racial blood pressure differences Hypertension 1 1979 468 475
13. R.S. Cooper, C.N. Rotimi, and R. Ward The puzzle of hypertension in African-Americans Sci Am 280 1999 56 63
14. The ARIC investigators The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives Am J Epidemiol 129 1989 687 702
15. M.T. Richardson, B.E. Ainsworth, H.C. Wu, D.R. Jacobs Jr., and A.S. Leon Ability of the Atherosclerosis Risk in Communities (ARIC)/Baecke Questionnaire to assess leisure-time physical activity Int J Epidemiol 24 1995 685 693
16. W.C. Willett, L. Sampson, M.J. Stampfer, B. Rosner, C. Bain, and J. Witschi Reproducibility and validity of a semiquantitative food frequency questionnaire Am J Epidemiol 122 1985 51 65
17. G.M. Fitzmaurice, N.M. laird, and J.H. Ware Applied longitudinal analysis Hoboken 2004 John Wiley New Jersey
18. C.H. Morrell, L.J. Brant, and L. Ferrucci Model choice can obscure results in longitudinal studies J Gerontol A Biol Sci Med Sci 64 2009 215 222
19. Y. Tatsukawa, W.L. Hsu, M. Yamada, J.B. Cologne, G. Suzuki, and H. Yamamoto White blood cell count, especially neutrophil count, as a predictor of hypertension in a Japanese population Hypertens Res 31 2008 1391 1397
20. A.C. Guyton, T.G. Coleman, A.V. Cowley Jr., K.W. Scheel, R.D. Manning Jr., and R.A. Norman Jr. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension Am J Med 52 1972 584 594
21. G. Bianchi, U. Fox, G.F. Di Francesco, A.M. Giovanetti, and D. Pagetti Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats Clin Sci Mol Med 47 1974 435 448
22. L.K. Dahl, and M. Heine Primary role of renal homografts in setting chronic blood pressure levels in rats Circ Res 36 1975 692 696
23. R. Rettig, C. Folberth, D. Kopf, H. Stauss, and T. Unger Role of the kidney in the pathogenesis of primary hypertension Clin Exp Hypertens A 12 1990 957 1002
24. J.J. Curtis, R.G. Luke, H.P. Dustan, M. Kashgarian, J.D. Whelchel, and P. Jones Remission of essential hypertension after renal transplantation New Engl J Med 309 1983 1009 1015
25. N. Tian, K.D. Thrasher, P.D. Gundy, M.D. Hughson, and R.D. Manning Jr. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension Hypertension 45 2005 934 939
26. N. Tian, R.A. Rose, S. Jordan, T.M. Dwyer, M.D. Hughson, and R.D. Manning Jr. N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension J Hypertens 24 2006 2263 2270
27. N. Tian, R.S. Moore, W.E. Phillips, L. Lin, S. Braddy, and J.S. Pryor NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension Am J Physiol Regul Integr Comp Physiol 295 2008 R1858 R1865
28. N. Tian, R.S. Moore, S. Braddy, R.A. Rose, J.W. Gu, and M.D. Hughson Interactions between oxidative stress and inflammation in salt-sensitive hypertension Am J Physiol Heart Circ Physiol 293 2007 H3388 H3395
29. N. Tian, J.W. Gu, S. Jordan, R.A. Rose, M.D. Hughson, and R.D. Manning Jr. Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension Am J Physiol Heart Circ Physiol 292 2007 H1018 H1025
30. H. Kobori, Y. Ozawa, Y. Suzaki, and A. Nishiyama Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats J Am Soc Nephrol 16 2005 2073 2080
31. H. Kobori, and A. Nishiyama Effects of Tempol on renal angiotensinogen production in Dahl salt-sensitive rats Biochem Biophys Res Commun 315 2004 746 750
32. L. Lin, W.E. Phillips, and R.D. Manning Intrarenal angiotensin II is associated with inflammation, renal damage and dysfunction in Dahl salt-sensitive hypertension J Am Soc Hypertens 3 2009 306 314
33. N.D. Vaziri, and B. Rodriguez-Iturbe Mechanisms of disease: oxidative stress and inflammation in the pathogenesis of hypertension Nat Clin Pract Nephrol 2 2006 582 593
34. C.S. Wilcox Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 289 2005 R913 R935
35. G.M. Rubanyi, and P.M. Vanhoutte Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor Am J Physiol 250 1986 H822 H827
36. T. Chabrashvili, A. Tojo, M.L. Onozato, C. Kitiyakara, M.T. Quinn, and T. Fujita Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney Hypertension 39 2002 269 274
37. S. Meng, L.J. Roberts, G.W. Cason, T.S. Curry, and R.D. Manning Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats Am J Physiol Regul Integr Comp Physiol 283 2002 R732 R738
38. S. Meng, G.W. Cason, A.W. Gannon, L.C. Racusen, and R.D. Manning Jr. Oxidative stress in Dahl salt-sensitive hypertension Hypertension 41 2003 1346 1352
39. K. Shen, F.A. DeLano, B.W. Zweifach, and G.W. Schmid-Schonbein Circulating leukocyte counts, activation, and degranulation in Dahl hypertensive rats Circ Res 76 1995 276 283
40. G.W. Schmid-Schonbein, D. Seiffge, F.A. DeLano, K. Shen, and B.W. Zweifach Leukocyte counts and activation in spontaneously hypertensive and normotensive rats Hypertension 17 1991 323 330
41. S. Sela, R. Mazor, M. Amsalam, C. Yagil, Y. Yagil, and B. Kristal Primed polymorphonuclear leukocytes, oxidative stress, and inflammation antecede hypertension in the Sabra rat Hypertension 44 2004 764 769
42. E. Hopps, P.R. Lo, and G. Caimi Pathophysiology of polymorphonuclear leukocyte in arterial hypertension Clin Hemorheol Microcirc 41 2009 209 218
43. F.R. Sheppard, M.R. Kelher, E.E. Moore, N.J. McLaughlin, A. Banerjee, and C.C. Silliman Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation J Leukoc Biol 78 2005 1025 1042
44. M.B. Hampton, A.J. Kettle, and C.C. Winterbourn Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing Blood 92 1998 3007 3017
45. M. Sedeek, R.L. Hebert, C.R. Kennedy, K.D. Burns, and R.M. Touyz Molecular mechanisms of hypertension: role of Nox family NADPH oxidases Curr Opin Nephrol Hypertens 18 2009 122 127
46. R. Ramasamy, M. Maqbool, A.L. Mohamed, and R.M. Noah Elevated neutrophil respiratory burst activity in essential hypertensive patients Cell Immunol 263 2010 230 234
47. D.S. Freedman, L. Gates, W.D. Flanders, O.W. Van Assendelft, J.J. Barboriak, and M.R. Joesoef Black/white differences in leukocyte subpopulations in men Int J Epidemiol 26 1997 757 764
48. D. Reich, M.A. Nalls, W.H. Kao, E.L. Akylbekova, A. Tandon, and N. Patterson Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene PLoS Genet 5 2009 e1000360
49. C. Elbim, and G. Lizard Flow cytometric investigation of neutrophil oxidative burst and apoptosis in physiological and pathological situations Cytometry A 75 2009 475 481
50. B. Kristal, R. Shurtz-Swirski, J. Chezar, J. Manaster, R. Levy, and G. Shapiro Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension Am J Hypertens 11 1998 921 928
51. E.P. Caetano, R. Zatz, and J.N. Praxedes The clinical diagnosis of hypertensive nephrosclerosis - how reliable is it? Nephrol Dial Transplant 14 1999 288 290 (Pubitemid 29062777)
52. B. Rodriguez-Iturbe, Y. Quiroz, J. Herrera-Acosta, R.J. Johnson, and H.A. Pons The role of immune cells infiltrating the kidney in the pathogenesis of salt-sensitive hypertension J Hypertens 20 Suppl 2002 S9 S14
53. T.J. Guzik, N.E. Hoch, K.A. Brown, L.A. McCann, A. Rahman, and S. Dikalov Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction J Exp Med 204 2007 2449 2460 (Pubitemid 47529329)
54. N. Takeichi, D. Ba, and H. Kobayashi Natural cytotoxic autoantibody against thymocytes in spontaneously hypertensive rats Cell Immunol 60 1981 181 190
55. H. Kvakan, M. Kleinewietfeld, F. Qadri, J.K. Park, R. Fischer, and I. Schwarz Regulatory T cells ameliorate angiotensin II-induced cardiac damage Circulation 119 2009 2904 2912
56. E.C. Viel, C.A. Lemarie, K. Benkirane, P. Paradis, and E.L. Schiffrin Immune regulation and vascular inflammation in genetic hypertension Am J Physiol Heart Circ Physiol 298 2010 H938 H944
57. S. Ulrich, M.R. Nicolls, L. Taraseviciene, R. Speich, and N. Voelkel Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension Respiration 75 2008 272 280
58. E.D. Austin, M.T. Rock, C.A. Mosse, C.L. Vnencak-Jones, S.M. Yoder, and I.M. Robbins T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension Respir Med 104 2010 454 462
59. Y. Bravo, Y. Quiroz, A. Ferrebuz, N.D. Vaziri, and B. Rodriguez-Iturbe Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension Am J Physiol Renal Physiol 293 2007 F616 F623
60. K.R. Pechman, D.P. Basile, H. Lund, and D.L. Mattson Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure Am J Physiol Regul Integr Comp Physiol 294 2008 R1234 R1239
61. D.L. Mattson, L. James, E.A. Berdan, and C.J. Meister Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat Hypertension 48 2006 149 156
62. J. Herrera, A. Ferrebuz, E.G. MacGregor, and B. Rodriguez-Iturbe Mycophenolate mofetil treatment improves hypertension in patients with psoriasis and rheumatoid arthritis J Am Soc Nephrol 17 2006 S218 S225